SEC Info℠

Home

Search

My Interests

Help

Sign In

Please Sign In

Medifocus Inc. – ‘20FR12G’ on 4/2/14 – ‘EX-4.7’

On:  Wednesday, 4/2/14, at 4:27pm ET   ·   Accession #:  1193125-14-128089   ·   File #:  0-55169

Previous ‘20FR12G’:  None   ·   Next:  ‘20FR12G’ on 9/17/14   ·   Latest:  ‘20FR12G/A’ on 12/2/14   ·   1 Reference:  By:  SEC – ‘UPLOAD’ on 5/2/14

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

 Text Wildcards:  ? (any letter/digit),  * (many).  Search Logic:  for Documents:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).  Details... 

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/02/14  Medifocus Inc.                    20FR12G               34:3.8M                                   Donnelley … Solutions/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 20FR12G     Registration of Securities of a Foreign Private     HTML    851K 
                          Issuer                                                 
 2: EX-1.1      Underwriting Agreement                              HTML     33K 
 3: EX-1.2      Underwriting Agreement                              HTML     19K 
 4: EX-1.3      Underwriting Agreement                              HTML     17K 
 5: EX-1.4      Underwriting Agreement                              HTML     14K 
 6: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML     23K 
                          Liquidation or Succession                              
 7: EX-4.1      Instrument Defining the Rights of Security Holders  HTML    113K 
16: EX-4.10     Instrument Defining the Rights of Security Holders  HTML    112K 
17: EX-4.11     Instrument Defining the Rights of Security Holders  HTML     32K 
18: EX-4.12     Instrument Defining the Rights of Security Holders  HTML     23K 
19: EX-4.13     Instrument Defining the Rights of Security Holders  HTML     25K 
20: EX-4.14     Instrument Defining the Rights of Security Holders  HTML     26K 
21: EX-4.15     Instrument Defining the Rights of Security Holders  HTML     19K 
22: EX-4.16     Instrument Defining the Rights of Security Holders  HTML     17K 
23: EX-4.17     Instrument Defining the Rights of Security Holders  HTML     98K 
24: EX-4.18     Instrument Defining the Rights of Security Holders  HTML    106K 
25: EX-4.19     Instrument Defining the Rights of Security Holders  HTML    130K 
 8: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     18K 
26: EX-4.20     Instrument Defining the Rights of Security Holders  HTML     74K 
27: EX-4.21     Instrument Defining the Rights of Security Holders  HTML     82K 
28: EX-4.22     Instrument Defining the Rights of Security Holders  HTML     46K 
29: EX-4.23     Instrument Defining the Rights of Security Holders  HTML     28K 
30: EX-4.24     Instrument Defining the Rights of Security Holders  HTML     73K 
31: EX-4.25     Instrument Defining the Rights of Security Holders  HTML     76K 
 9: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     17K 
10: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     86K 
11: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     92K 
12: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     45K 
13: EX-4.7      Instrument Defining the Rights of Security Holders  HTML     72K 
14: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     22K 
15: EX-4.9      Instrument Defining the Rights of Security Holders  HTML     17K 
32: EX-8.1      Opinion re: Tax Matters                             HTML     10K 
33: EX-15.1     Letter re: Unaudited Interim Financial Information  HTML     12K 
34: EX-15.2     Letter re: Unaudited Interim Financial Information  HTML     14K 

Exhibit 4.7

PATENT ASSIGNMENT

This Patent Assignment is made and entered into as of July 24, 2012 by and between

1) Boston Scientific Corporation;

2) Boston Scientific Scimed, Inc.; and

3) Boston Scientific Limited

(collectively, the “Assignors”) and Medifocus, Inc. (“Assignee”) (collectively referred to as the “Parties”).

WHEREAS, the Assignors are the owners of certain intellectual property rights, including the patents and patent applications listed on Schedule 1 attached hereto (collectively referred to herein as the “Patents”); and

WHEREAS, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Assignors desire to sell, transfer, assign and set over unto Assignee all rights, title, and interest of the Assignors in and to the Patents.

NOW, THEREFORE, the Assignors do hereby sell, assign, transfer and set over unto the Assignee, its successors and assigns, the entire and exclusive right, title and interest in and to all inventions in the United States and throughout the world (with priority rights) in and to the Patents, and in and to any continuations, continuations-in-part, divisions, reissues, extensions and foreign counterparts of the Patents, together with all claims for damages by reason of past infringement of any Patents, with the right to sue for and collect the same. Assignors further agree to execute and have executed all documents, instruments and papers to perform all acts, as deemed reasonably necessary by Assignee to perfect in Assignee the foregoing rights, title and interests, including the execution of any related domestic or foreign application documents, provided that all costs and expenses associated with the recordation of assignment documents shall be born equally by Assignee and Assignor.

This Patent Assignment may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

[Remainder of this page intentionally left blank]

IN WITNESS WHEREOF, the undersigned has caused this Patent Assignment to be duly executed and delivered as of the date first written above.

On this 23rd day of July, 2012, before me, the undersigned, a Notary Public in and for the Commonwealth of Massachusetts, duly commissioned and sworn, personally appeared Thomas G. Robinson, to me known to be the Vice President, Strategy and Business Development, Urology and Women’s Health, of Boston Scientific Corporation, the corporation that executed the within and foregoing instrument, and acknowledged said instrument to be free and voluntary deed of said corporation for the uses and the purposes therein mentioned, and on oath stated that he was authorized to execute said instrument.

[Signature Page to Patent Assignment]

On this 20th day of July, 2012, before me, the undersigned, a Notary Public in and for the Commonwealth of Massachusetts, duly commissioned and sworn, personally appeared Vance R. Brown, to me known to be the Vice President and Secretary of Boston Scientific Scimed, Inc., the corporation that executed the within and foregoing instrument, and acknowledged said instrument to be free and voluntary deed of said corporation for the uses and the purposes therein mentioned, and on oath stated that he was authorized to execute said instrument.

[Signature Page to Patent Assignment]

On this 20th day of July, 2012, before me, the undersigned, a Notary Public in and for the Commonwealth of Massachusetts, duly commissioned and sworn, personally appeared Vance R. Brown, to me known to be the Vice President and Secretary of Boston Scientific Limited, the corporation that executed the within and foregoing instrument, and acknowledged said instrument to be free and voluntary deed of said corporation for the uses and the purposes therein mentioned, and on oath stated that he was authorized to execute said instrument.

[Signature Page to Patent Assignment]

[Signature Page to Patent Assignment]

Schedule 1

Assigned Patents and Patent Applications

---

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘20FR12G’ Filing		Date		Other Filings
		7/6/18
		7/16/15		20-F
		5/1/14
Filed on:		4/2/14
		7/24/12
				List all Filings

---

1 Subsequent Filing that References this Filing

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/02/14 SEC UPLOAD¶ 10/06/17 1:70K Medifocus Inc.

↑Top

---

Filing Submission 0001193125-14-128089   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

---

---

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., May 5, 6:29:44.1am ET